The Journal of Antimicrobial Chemotherapy
Volume 69 Number 12 December 2014
Systematic reviews
Virological efficacy of abacavir: systematic review and meta-analysis
Mario Cruciani, Carlo Mengoli, Marina Malena, Giovanni Serpelloni, Saverio G. Parisi, Graeme Moyle and
Oliviero Bosco
Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on
randomized controlled trials
Wenqiang He, Yawei Zhang, Hongbin Chen, Chunjiang Zhao and Hui Wang
Original research
Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges
in VraS
Anne Berscheid, Patrice Franc¸ois, Axel Strittmatter, Gerhard Gottschalk, Jacques Schrenzel, Peter Sass and
Gabriele Bierbaum
Kinetics of recA and recX induction in drug-susceptible and MDR clinical strains of
Mycobacterium tuberculosis
Purva Bhatter, Anirvan Chatterjee and Nerges Mistry
Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial
fitness in Escherichia coli
Jesu´s Machuca, Alejandra Briales, Gema Labrador, Paula Dı´az-de-Alba, Rafael Lo´pez-Rojas,
Fernando Docobo-Pe´rez, Luis Martı´nez-Martı´nez, Jesu´s Rodrı´guez-Ban˜o, Maria Eugenia Pacho´n, A´lvaro Pascual
and Jose´-Manuel Rodrı´guez-Martı´nez
Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical
Eliane Siebor and Catherine Neuwirth
MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance,
oxidative and envelope stress tolerances and biofilm formation
Yi-Tsung Lin, Yi-Wei Huang, Rung-Shiuan Liou, Yi-Chih Chang and Tsuey-Ching Yang
Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics
Muhammad Malik, Liping Li, Xilin Zhao, Robert J. Kerns, James M. Berger and Karl Drlica
Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria
alone and in combination with colistin
Yoann Personne, Michael A. Curtis, David W. Wareham and Richard D. Waite
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole
but maintained susceptibility to itraconazole and posaconazole
J. Lescar, I. Meyer, K. Akshita, K. Srinivasaraghavan, C. Verma, M. Palous, D. Mazier, A. Datry and A. Fekkar
Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19
Rosalba Perrone, Elena Butovskaya, Dirk Daelemans, Giorgio Palu`, Christophe Pannecouque and
Sara N. Richter
Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US
G. V. Sanchez, A. M. G. Baird, J. A. Karlowsky, R. N. Master and J. M. Bordon
Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid),
taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of
biofilm-producing staphylococci from central venous catheters
Megan K. Luther, Leonard A. Mermel and Kerry L. LaPlante
Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis
M. Jesu´s Corral, Dolores R. Serrano, Inmaculada Moreno, J. J. Torrado, Mercedes Domı´nguez and
Jose´ M. Alunda
A multisystem investigation of raltegravir association with intestinal tissue: implications for pre-exposure
prophylaxis and eradication
Darren M. Moss, Paul Curley, Alison Shone, Marco Siccardi and Andrew Owen
Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects
from HSV-2 infection
Gita N. Shankar and Carsten Alt
Pharmacokinetics of caspofungin in ICU patients
E. W. Muilwijk, J. A. Schouten, H. J. van Leeuwen, A. R. H. van Zanten, D. W. de Lange, A. Colbers, P. E. Verweij,
D. M. Burger, P. Pickkers and R. J. M. Bru¨ggemann
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical
Trials Group Study A5202
Charles S. Venuto, Katie Mollan, Qing Ma, Eric S. Daar, Paul E. Sax, Margaret Fischl, Ann C. Collier,
Kimberly Y. Smith, Camlin Tierney and Gene D. Morse on behalf of the AIDS Clinical Trials Group Study
A5202 Team
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4b-hydroxycholesterol
during efavirenz treatment and efavirenz/rifampicin co-treatment
E. Ngaimisi, O. Minzi, S. Mugusi, P. Sasi, K.-D. Riedel, A. Suda, N. Ueda, M. Bakari, M. Janabi, F. Mugusi,
L. Bertilsson, J. Burhenne, E. Aklillu and U. Diczfalusy
Single-nucleotide polymorphisms in the UDP-glucuronosyltransferase 1A-30 untranslated region are
associated with atazanavir-induced nephrolithiasis in patients with HIV-1 infection: a pharmacogenetic
Takeshi Nishijima, Kiyoto Tsuchiya, Noriko Tanaka, Akane Joya, Yohei Hamada, Daisuke Mizushima,
Takahiro Aoki, Koji Watanabe, Ei Kinai, Haruhito Honda, Hirohisa Yazaki, Junko Tanuma, Kunihisa Tsukada,
Katsuji Teruya, Yoshimi Kikuchi, Shinichi Oka and Hiroyuki Gatanaga
CYP2B6 c.983T.C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan
HIV populations
Daniel F. Carr, Mas Chaponda, Elena M. Cornejo Castro, Andrea L. Jorgensen, Saye Khoo,
Joep J. Van Oosterhout, Collet Dandara, Elizabeth Kampira, Francis Ssali, Paula Munderi, David G. Lalloo,
Robert S. Heyderman and Munir Pirmohamed
Initiation of rilpivirine, tenofovir and emtricitabine (RPV/TDF/FTC) regimen in 363 patients with virological
vigilance assessment in ‘real life’
Corinne Amiel, Veronique Schneider, Sabine Guessant, Mohammed Hamidi, Khadijah Kherallah,
Marie-Gisele Lebrette, Julie Chas, Catherine Lependeven and Gilles Pialoux
Phenotypic characterization of virological failure following lopinavir/ritonavir monotherapy using full-length
gag – protease genes
Katherine A. Sutherland, Jean L. Mbisa, Jade Ghosn, Marie-Laure Chaix, Isabelle Cohen-Codar, Stephane Hue,
Jean-Francois Delfraissy, Constance Delaugerre and Ravindra K. Gupta
Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing:
implications for use in low- and middle-income countries
Halime Ekici, Shwetha D. Rao, Anders So¨nnerborg, Vedam L. Ramprasad, Ravi Gupta and Ujjwal Neogi
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating
a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study
S. Seang, S. Fourati, Y. Keita, C. Blanc, R. Tubiana, L. Schneider, M. A. Valantin, F. Caby, R. Calin,
S. Lambert-Niclot, A.-G. Marcelin, V. Calvez, D. Costagliola and C. Katlama
Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies
and haematological parameters
Laurence Slama, Frank J. Palella Jr, Alison G. Abraham, Xiuhong Li, Corinne Vigouroux, Gilles Pialoux,
Lawrence Kingsley, Jordan E. Lake and Todd T. Brown on behalf of the Multicenter AIDS Cohort Study (MACS)
Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients
with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)
Euge`nia Negredo, Pere Domingo, Nu´ria Pe´rez-A´lvarez, Mar Gutie´rrez, Gracia Mateo, Jordi Puig, Roser Escrig,
Patricia Echeverrı´a, Anna Bonjoch and Bonaventura Clotet
Antibiotic prophylaxis for transrectal prostate biopsy—a new strategy
Valeria Antsupova, Nis Nørgaard, Rasmus Bisbjerg, Jette Nygaard Jensen, Jonas Boel, Jens Otto Jarløv and
Magnus Arpi
Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre,
randomized, double-blind, active-controlled study
Xi-sheng Leng, Yong-jie Zhao, Hui-zhong Qiu, Yong-kuan Cao, Wei-hua Zhu, Ju-fang Shen, Amanda Paschke,
Wei-min Dai, Nicole Caldwell and Jue Wang
A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in
high-risk patients with haematological malignancies
Maria J. G. T. Vehreschild, Axel Hamprecht, Lisa Peterson, So¨ren Schubert, Maik Ha¨ntschel, Silke Peter,
Philippe Schafhausen, Holger Rohde, Marie v. Lilienfeld-Toal, Isabelle Bekeredjian-Ding, Johannes Libam,
Martin Hellmich, Jo¨rg J. Vehreschild, Oliver A. Cornely and Harald Seifert
Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a
Victoire de Lastours, Franc¸oise Chau, Carine Roy, Beatrice Larroque and Bruno Fantin
Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the
treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between
2005 and 2010
Makoto Jones, Benedikt Huttner, Molly Leecaster, Angela Huttner, Kavitha Damal, Windy Tanner,
Christopher Nielson, Michael A. Rubin, Matthew Bidwell Goetz, Karl Madaras-Kelly and Matthew H. Samore
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial
non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in
Luke S. P. Moore, Rachel Freeman, Mark J. Gilchrist, Myriam Gharbi, Eimear T. Brannigan, Hugo Donaldson,
David M. Livermore and Alison H. Holmes
Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations
to reduce antibiotic resistance, UK 1995 – 2011: analysis of a large database of primary care consultations
Jeremy I. Hawker, Sue Smith, Gillian E. Smith, Roger Morbey, Alan P. Johnson, Douglas M. Fleming,
Laura Shallcross and Andrew C. Hayward
Research letters
A survey of metallo-b-lactamase sequence accuracy before the data deluge
Katinka I. Apagyi and Matthew J. Ellington
Amikacin resistance plasmids in extensively antibiotic-resistant GC2 Acinetobacter baumannii from two
Australian hospitals
Steven J. Nigro and Ruth M. Hall
Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006
Ignasi Roca, Noraida Mosqueda, Belgin Altun, Paula Espinal, Murat Akova and Jordi Vila
New case of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in Belgium
Isabel Montesinos, Magali Dodemont, Katrien Lagrou, Frederique Jacobs, Isabelle Etienne and Olivier Denis
Combination testing of colistin with telavancin and daptomycin
K. E. Milne and I. M. Gould
Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery
Bettina M. Knoll
Letters to the Editor
Comment on: Effects of selective digestive decontamination (SDD) on the gut resistome
J. Hatcher, A. Myers, H. Donaldson, A. C. Gordon, R. Meacher and J. Baruah
Comment on: Measurement units for antibiotic consumption in outpatients
Samuel Coenen, Robin Bruyndonckx, Niel Hens, Marc Aerts and Herman Goossens
Acknowledgement to referees